Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Other Non Operating Income (2022 - 2025)

Envoy Medical's Other Non Operating Income history spans 4 years, with the latest figure at $5000.0 for Q3 2025.

  • For Q3 2025, Other Non Operating Income fell 66.67% year-over-year to $5000.0; the TTM value through Sep 2025 reached -$136000.0, down 101.02%, while the annual FY2024 figure was -$26000.0, 62.32% up from the prior year.
  • Other Non Operating Income for Q3 2025 was $5000.0 at Envoy Medical, up from -$1000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $13.3 million in Q4 2023 and bottomed at -$9.4 million in Q1 2023.
  • The 4-year median for Other Non Operating Income is $10000.0 (2024), against an average of $1.1 million.
  • The largest annual shift saw Other Non Operating Income soared 101.1% in 2024 before it crashed 110.68% in 2025.
  • A 4-year view of Other Non Operating Income shows it stood at $574000.0 in 2022, then skyrocketed by 2210.63% to $13.3 million in 2023, then tumbled by 100.97% to -$129000.0 in 2024, then surged by 103.88% to $5000.0 in 2025.
  • Per Business Quant, the three most recent readings for COCH's Other Non Operating Income are $5000.0 (Q3 2025), -$1000.0 (Q2 2025), and -$11000.0 (Q1 2025).